SHAREHOLDER ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Portola Pharmaceuticals Inc. - PTLA
NEW YORK, September 6, 2017 /PRNewswire/ -- Pomerantz LLP is investigating claims on behalf of investors of Portola Pharmaceuticals Inc. ("Portola" or the "Company") (NASDAQ: PTLA). Such investors are advised to contact Robert S. Willoughby at [email protected] or 888-476-6529, ext. 9980.
The investigation concerns whether Portola and certain of its officers and/or directors have engaged in securities fraud or other unlawful business practices.
[Click here to join a class action]
On September 5, 2017, post-market, Portola announced that the Company's oral anticoagulant Bevyxxa (betrixaban) would launch in November 2017 at the earliest, and possibly as late as the first quarter of 2018. Having previously projected a September 2017 launch for Bevyxxa, Portola advised investors that the U.S. Food and Drug Administration would require additional time to complete review of a post-approval change to the product.
On this news, Portola's share price has fallen as much as $3.83, or 6.44%, during intraday trading on September 6, 2017.
The Pomerantz Firm, with offices in New York, Chicago, Los Angeles, and Paris, is acknowledged as one of the premier firms in the areas of corporate, securities, and antitrust class litigation. Founded by the late Abraham L. Pomerantz, tecknown as the dean of the class action bar, the Pomerantz Firm pioneered the field of securities class actions. Today, more than 80 years later, the Pomerantz Firm continues in the tradition he established, fighting for the rights of the victims of securities fraud, breaches of fiduciary duty, and corporate misconduct. The Firm has recovered numerous multimillion-dollar damages awards on behalf of class members. See www.pomerantzlaw.com
CONTACT:
Robert S. Willoughby
Pomerantz LLP
SOURCE Pomerantz LLP
Related Links
WANT YOUR COMPANY'S NEWS FEATURED ON PRNEWSWIRE.COM?
Newsrooms &
Influencers
Digital Media
Outlets
Journalists
Opted In
Share this article